---
category: trading
circular_id: 7f921d6e0cbfcd66
date: '2025-10-08'
description: 'Sheel Biotech Limited to be transferred from trade for trade segment
  (series: ST) to rolling segment (Series: SM) effective October 24, 2025.'
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML70692.pdf
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine segment transfer for a single SME stock from trade-for-trade
  to rolling segment, limited market-wide impact
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML70692.pdf
processing:
  attempts: 1
  content_hash: c65965e40edd48fd
  processed_at: '2025-10-08T12:44:21.019653'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-10-08T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML70692.pdf
severity: low
source: nse
stocks:
- SHEEL
tags:
- listing
- rolling-segment
- segment-transfer
- sme
- trade-for-trade
title: Trade for Trade - Sheel Biotech Limited (SME IPO)
---

## Summary

Sheel Biotech Limited will be transferred from the trade for trade segment (series: ST) to the rolling segment (Series: SM) effective October 24, 2025. This follows Exchange Circular no. NSE/CML/70685 dated October 07, 2025 and is pursuant to SEBI guidelines under circular reference no. CIR/MRD/DP/02/2012 dated January 20, 2012.

## Key Points

- Security Symbol: SHEEL
- Company Name: Sheel Biotech Limited
- Movement from Trade for Trade segment (Series: ST) to Rolling segment (Series: SM)
- This is a routine post-IPO segment transfer for an SME listing

## Regulatory Changes

No new regulatory changes. This action is pursuant to existing SEBI guidelines (CIR/MRD/DP/02/2012 dated January 20, 2012) governing segment transfers for securities.

## Compliance Requirements

No specific compliance requirements for market participants. This is an administrative segment transfer managed by the Exchange.

## Important Dates

- **Circular Date**: October 08, 2025
- **Effective Date**: October 24, 2025 - Sheel Biotech Limited transfers to rolling segment

## Impact Assessment

Minimal market impact. This is a standard procedural transfer for a single SME stock following its IPO. The move to rolling segment allows for normal T+2 settlement instead of trade-for-trade settlement, potentially improving liquidity for the security. Impact is limited to traders and investors specifically dealing with SHEEL stock.